middle.news
Orthocell Posts Record $13.2M FY2026 Revenue with US and Global Growth
8:53am on Monday 13th of July, 2026 AEST
•
Healthcare
Read Story
Orthocell Posts Record $13.2M FY2026 Revenue with US and Global Growth
8:53am on Monday 13th of July, 2026 AEST
Key Points
Record quarterly revenue of $3.8 million, up 20% from prior quarter
FY2026 revenue climbs 44% to $13.2 million
US Remplir sales and hospital adoption accelerate
Regulatory approval for UK/EU Remplir expected by end 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE